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A B S T R A C T
Background
Current international treatment guidelines recommending therapeutic exercise for people with symptomatic hip osteoarthritis (OA)
report are based on limited evidence.
Objectives
To determine whether land-based therapeutic exercise is beneficial for people with hip OA in terms of reduced joint pain and improved
physical function and quality of life.
Search methods
We searched five databases from inception up to February 2013.
Selection criteria
All randomised controlled trials (RCTs) recruiting people with hip OA and comparing some form of land-based therapeutic exercise
(as opposed to exercises conducted in water) with a non-exercise group.
Data collection and analysis
Four review authors independently selected studies for inclusion. We resolved disagreements through consensus. Two review authors
independently extracted data, assessed risk of bias and the quality of the body of evidence for each outcome using the GRADE approach.
We conducted analyses on continuous outcomes (pain, physical function and quality of life) and dichotomous outcomes (proportion
of study withdrawals).
Main results
We considered that seven of the 10 included RCTs had a low risk of bias. However, the results may be vulnerable to performance and
detection bias as none of the RCTs were able to blind participants to treatment allocation and, while most RCTs reported blinded
outcome assessment, pain, physical function and quality of life were participant self reported. One of the 10 RCTs was only reported
as a conference abstract and did not provide sufficient data for the evaluation of bias risk.
High-quality evidence from nine trials (549 participants) indicated that exercise reduced pain (standardised mean difference (SMD) -
0.38, 95% confidence interval (CI) -0.55 to -0.20) and improved physical function (SMD -0.38, 95% CI -0.54 to -0.05) immediately
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after treatment. Pain and physical function were estimated to be 29 points on a 0- to 100-point scale (0 was no pain or loss of physical
function) in the control group; exercise reduced pain by an equivalent of 8 points (95% CI 4 to 11 points; number needed to treat for an
additional beneficial outcome (NNTB) 6) and improved physical function by an equivalent of 7 points (95% CI 1 to 12 points; NNTB
6). Only three small studies (183 participants) evaluated quality of life, with overall low quality evidence, with no benefit of exercise
demonstrated (SMD -0.07, 95% CI -0.23 to 0.36). Quality of life was estimated to be 50 points on a norm-based mean (standard
deviation (SD)) score of 50 (10) in the general population in the control group; exercise improved quality of life by 0 points. Moderate-
quality evidence from seven trials (715 participants) indicated an increased likelihood of withdrawal from the exercise allocation (event
rate 6%) compared with the control group (event rate 3%), but this difference was not significant (risk difference 1%; 95% CI -1%
to 4%). Of the five studies reporting adverse events, each study reported only one or two events and all were related to increased pain
attributed to the exercise programme.
The reduction in pain was sustained at least three to six months after ceasing monitored treatment (five RCTs, 391 participants): pain
(SMD -0.38, 95% CI -0.58 to -0.18). Pain was estimated to be 29 points on a 0- to 100-point scale (0 was no pain) in the control
group, the improvement in pain translated to a sustained reduction in pain intensity of 8 points (95%CI 4 to 12 points) compared with
the control group (0 to 100 scale). The improvement in physical function was also sustained (five RCTs, 367 participants): physical
function (SMD -0.37, 95% CI -0.57 to -0.16). Physical function was estimated to be 24 points on a 0- to 100-point scale (0 was no
loss of physical function) in the control group, the improvement translated to a mean of 7 points (95% CI 4 to 13) compared with the
control group.
Only five of the 10 RCTs exclusively recruited people with symptomatic hip OA (419 participants). There was no significant difference
in pain or physical function outcomes compared with five studies recruiting participants with hip or knee OA (130 participants).
Authors’ conclusions
Pooling the results of these 10 RCTs demonstrated that land-based therapeutic exercise programmes can reduce pain and improve
physical function among people with symptomatic hip OA.
P L A I N L A N G U A G E S U M M A R Y
Exercise for osteoarthritis of the hip
Background - what is OA of the hip and what is exercise?
OA is a disease of the joints, such as your hip. When the joint loses cartilage, the bone grows to try to repair the damage. However,
instead of making things better, the bone grows abnormally and makes things worse. For example, the bone can become misshapen
and make the joint painful and unstable. Doctors used to think that osteoarthritis (OA) simply resulted in thinning of the cartilage.
However, it is now known that OA is a disease of the whole joint.
OA is one of the most common forms of arthritis and affects men and women equally. OA is one of the main causes of disability as
people grow older.
Exercise can be any activity that enhances or maintains muscle strength, physical fitness and overall health. People exercise for many
different reasons including weight loss, strengthening muscles and to relieve the symptoms of OA.
Study characteristics
This summary of an update of a Cochrane review presents what we know from research about the effect of exercise for people with
OA of the hip. After searching for all relevant studies up to February 2013, we included five new studies since the last version of the
review, giving 10 studies (549 participants) with mostly mild-to-moderate symptomatic hip OA, alone or with knee OA. Except for one
study where participants enrolled in a tai chi programme, all other participants underwent land-based exercise programmes consisting
of traditional muscle strengthening, functional training and aerobic fitness programmes, either individually supervised or as part of a
group, compared with people who did not exercise.
Key results
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Pain on a scale of 0 to 100 points (lower scores mean reduced pain):
- People who completed an exercise programme rated their pain to be 8 points lower (4 to 11 points lower) at end of treatment (8%
absolute improvement) compared with people who did not exercise.
- People who completed an exercise programme rated their pain as 21 points.
- People who did not exercise rated their pain as 29 points.
Physical function on a scale of 0 to 100 points (lower score means better physical function):
- People who completed an exercise programme rated their physical function to be 7 points lower (1 to 12 points lower) at end of
treatment (7% absolute improvement) compared with people who did not exercise.
- People who completed an exercise programme rated their physical function as 22 points.
- People who did not exercise rated their physical function as 29 points.
Quality of life (higher score means better quality of life):
- Overall, people with hip OA participating in the studies had a similar quality of life compared with the general population (normative
scores of average 50 points), and quality of life was not further improved by participation in an exercise programme: 0 points higher.
- People who completed an exercise programme rated their quality of life as 50 points on a population norm-based scale.
- People who did not exercise rated their quality of life as 50 points on a population norm-based scale.
Withdrawals
- three more people out of 100 dropped out of the exercise programme (1% absolute increase).
- Six out of 100 people in exercise programmes dropped out.
- Three out of 100 people who did not exercise dropped out.
Quality of the evidence
This review showed that there is high-quality evidence that in people with hip OA, exercise reduced pain slightly and improved physical
function slightly. Further research is unlikely to change the estimate of these results.
Low-quality evidence indicated that exercise may not improve quality of life. Further research is likely to change the estimate of these
results.
Moderate-quality evidence showed that exercise probably does not increase study drop-outs. Further research may change the estimate.
We do not have precise information about side effects such as injuries or falls during exercise, but we would expect these to be rare, and
no injuries were reported in the studies.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Immediate post-treatment effect of exercise for osteoarthritis of the hip
Patient or population: people with osteoarthritis of the hip
Settings:
Intervention: land-based exercise
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Land-based exercise
Pain
Self report
The mean pain ranged
across control groups
from
29 points on a 0-100
scale
(lower score is better)
The mean pain in the in-
tervention groups was
8 points lower (4 to 11
points lower) compared
with control group using
a 0-100 scale1
- 549
(9 studies)
⊕⊕⊕⊕
high
SMD -0.38 (-0.55 to -0.
2)
Absolute change: 8 points
(4 to 11) on a 0-100 scale
Relative change 28%
(14% to 38%)1
NNTB: 6 (4 to 11)
Physical function The mean physical func-
tion ranged across con-
trol groups from 29
points on a 0-100 scale
to 36 points on a 0-68
scale
(lower score is better)
The mean physical func-
tion in the intervention
groups was 7 points
lower
(1 to 12 points lower)
compared with control
group using a 0 to100
scale2
- 521
(9 studies)
⊕⊕⊕⊕
high
SMD -0.33 (-0.54 to -0.
05)
Absolute change: 7 points
(1 to 12) on a 0-100 scale
Relative change: 24%
(3% to 42%) 2
NNTB: 6 (4 to 41)
Quality of life Mean quality of life in
the control group was
estimated as 50 points,
based on a population
norm-based scale
Quality of life improved by
0 points
- 183
(3 studies)
⊕⊕©©
low3,4
SMD 0.07 (-0.23, 0.36)
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Withdrawals or dropouts 34 per 1000 59 per 1000
(30 to 114)
OR 1.77
(0.86 to 3.65)
715
(7 studies)
⊕⊕⊕©
moderate5
Absolute risk difference:
1% more events (1%
fewer to 4% more)
Relative difference: 68%
increase (13% decrease
to 224% increase)
Adverse events
not reported
See comment See comment Not estimable - See comment No adverse events such
as injuries were reported
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; NNTB: number needed to treat for an additional beneficial outcome
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1. Control group baseline mean (standard deviation) was 29.1 (20.2) points on 0- to 100-point scale (Juhakoski 2011).
2. Control group baseline mean (standard deviation) was 28.9 (22.4) points on 0- to 100-point scale (Juhakoski 2011).
3. Potential imprecision, as outcome only reported in three studies.
4. Indirectness: quality of life does not appear to be influenced by mild-to-moderate symptomatic hip OA as the quality of life assessment
reported in the two studies using the SF-MCS was in line with published population-based normative values.
5. Imprecison as the number of events were small, and the outcome was poorly reported; many studies reported the number of
participants attending outcomes assessments, but did not provide quantitative data regarding the number of participants withdrawing
from study treatment.
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B A C K G R O U N D
Description of the condition
The prevalence of symptomatic radiographic hip osteoarthritis
(OA) increases with age and is estimated to be around 5% to 15%
for among white people aged 55 years and over (Lawrence 1998;
Odding 1998; Moskowitz 2007; Busija 2010). Symptomatic hip
OA is associatedwith joint pain, physical disability andpoor health
status (Croft 2002; Dawson 2004), and is the most common rea-
son for total hip replacement surgery. While progression between
onset of hip pain to severe symptoms and end-stage disease is vari-
able, disease progression generally appears to be much more rapid
than that observed in knee OA (Arden 2006).
How the intervention might work
Risk factors for incident hip OA include a wide range of local
and systemic factors (Arden 2006; Lane 2007; Moskowitz 2007).
While age, genetic disposition and many musculoskeletal comor-
bidity causing hip OA (Paget’s disease, developmental deformi-
ties of the hip joint, rheumatoid arthritis, etc.) are arguably not
modifiable risk factors, improving the mechanical environment of
the hip joint and reducing joint loading in this weight-bearing
joint have some face validity as useful therapeutic interventions
(Zhang 2008). In support, it has been shown that hipOA is associ-
ated with markedly reduced lower limbmuscle strength (Arokoski
2002; Suetta 2007), and occupations involving a heavy physical
load (Fransen 2011).
Why it is important to do this review
There is no cure for hip OA or treatments proven to slow dis-
ease progression. The main treatment goal for people with hip
OA, therefore, is to reduce joint pain and physical disability. Cur-
rent international guidelines for the treatment of hip OA recom-
mend strengthening exercises based on the evidence provided by
one meta-analysis (Hernandez-Molina 2008) of benefit in terms
of pain reduction (Zhang 2010). However, the 95% confidence
intervals (CI) around the reported small treatment effect (0.38)
were wide (0.08 to 0.68) and there is currently no evidence of
treatment benefit in terms of physical function.
O B J E C T I V E S
To determine whether land-based therapeutic exercise is beneficial
for people with hip OA in terms of reduced joint pain, improved
physical function and improved quality of life.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) or controlled clinical (quasi-
randomised) trials comparing some formof land-based therapeutic
exercise with a non-exercise group.
Types of participants
Adults, men or women, with either an established diagnosis of
hip OA according to accepted criteria or self reporting hip OA
on the basis of chronic anterior joint pain (without radiographic
confirmation).
Types of interventions
Any land-based therapeutic exercise regimens aiming to relieve the
symptoms of hip OA, regardless of content, duration, frequency
or intensity. This included any exercise designed improve muscle
strength, range of joint movement or aerobic capacity (or com-
binations of the three). Programmes could be designed and su-
pervised by physiotherapists or other professionals, or provided
as a home programme with minimal monitoring. We included
pre-surgery (total hip replacement) programmes. The comparator
(control) group could be active (any non-exercise intervention) or
placebo (no treatment or waiting list) group. We excluded stud-
ies that compared one type of exercise programme versus another
exercise programme, provided an exercise programme to all treat-
ment allocations (and evaluated the added benefit of an electro-
physical agent or hydrotherapy), compared exercise with manual
therapy and compared programmes of varying intensities.
Types of outcome measures
In accordance with international consensus regarding the core set
of outcome measures for phase III clinical trials in OA (Bellamy
1997), the RCT needed to include assessment of at least one of:
• hip pain;
• self reported physical function;
• quality of life.
We assessed these outcomes at two time points: immediately at
the end of treatment (post-treatment) and long-term follow-up
(sustainability).
In addition, we noted the number of participants withdrawing
from the study prior to the post-treatment assessment and the
number of participants experiencing adverse events, if provided.
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Search methods for identification of studies
We searched five databases were searched from inception to
February 2013, with no restriction on language: MEDLINE
(Appendix 1), EMBASE (Ovid) (Appendix 2), PEDro (Physio-
therapy Evidence Database) (Appendix 3), CINAHL (EBSCO-
host) (Appendix 4) and The Cochrane Library (Wiley Interscience)
(Appendix 5).
We also included a search of
ClinicalTrials.gov (www.ClinicalTrials.gov) and the WHO trials
portal (www.who.int/ictrp/en/).
Data collection and analysis
Selection of studies
Three review authors (MF, SM, GH) independently screened re-
trieved clinical studies for inclusion. If we did not reach an agree-
ment at any stage, a fourth review author (SR) adjudicated.
Data extraction and management
Three review authors (MF, SM, GH) extracted data from all in-
cluded studies and conducted the risk of bias assessment. If we did
not reach an agreement at any stage, a fourth review author (SR)
adjudicated.
If data on more than one pain scale were provided for a trial,
we extracted data from the pain scale that was highest on this
list according to a previously described hierarchy of pain-related
outcomes (Juni 2006; Reichenbach 2007):
1. Global pain;
2. Pain on walking;
3. Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC) pain subscore;
4. Composite pain scores other than WOMAC;
5. Pain on activities other than walking;
6. Rest pain or pain during the night;
7. WOMAC global algofunctional score;
8. Lequesne Osteoarthritis Index global score;
9. Other algofunctional scale.
If data on more than one physical function scale were reported in
a trial, data were extracted according to the hierarchy presented
below:
1. Global disability score;
2. Walking disability;
3. WOMAC disability subscore;
4. Composite disability scores other than WOMAC;
5. Disability other than walking;
6. WOMAC global scale;
7. Lequesne Osteoarthritis Index global score;
8. other algofunctional scale.
If data on more than one quality of life scale were reported in
a trial, data were extracted according to the hierarchy presented
below:
1. 36-item Short Form (SF-36), Mental Component
Summary (MCS);
2. 12-item Short Form (SF-12) MCS;
3. EuroQol;
4. Sickness Impact Profile (SIP);
5. Nottingham Health Profile (NHP);
6. other quality of life scales.
Assessment of risk of bias in included studies
We assessed the risk of bias of included studies in accordance with
The Cochrane Collaboration’s recommended methods (Risk of
bias in included studies).
We assessed the risk of bias according to the following domains.
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective outcome reporting.
7. Other bias (baseline imbalances between allocation groups
in participant characteristics, occurrence of ’null bias’ due to
exercise intervention being mostly unmonitored or lengthy
period between end of monitored treatment and assessment of
outcomes).
We assessed each potential source of bias as high, lowor unclear and
provided a quote from the study report together with a justification
for our judgement in the ’Risk of bias’ table. We summarised the
risk of bias judgements across different studies for each of the
domains listed.
Where information on risk of bias related to unpublished data or
correspondence with a trialist, we noted this in the ’Risk of bias’
table.
We presented the figures generated by the ’Risk of bias’ tool to
provide summary assessments of the risk of bias.
If the random sequence generation, allocation concealment and
incomplete outcome data domain were adequately met in a study,
we judged the overall risk of bias as low for that study.
Measures of treatment effect
As the studies used a variety of continuous scales to evaluate pain,
physical function and quality of life outcomes, a unitless measure
of treatment effect sizewas needed to allow the results of the various
RCTs to be combined. We used standardised mean differences
(SMD) to calculate treatment effect sizes from the endof treatment
scores and related standard deviation (SD) scores, where possible.
Therefore, the treatment effect size is a unitless measure providing
an indication of the size of the change in terms of its variability.
Outcomes pooled using SMDwere re-expressed as absolute mean
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difference using a representative control group (high weighting in
pooled analyses) baseline SD. We pooled Mantel-Haenszel odds
ratios (OR) to calculate the effect of treatment allocation on study
withdrawal prior to the first outcomes assessment.
Unit of analysis issues
The unit of analysis was the participant, and thus there were no
unit of analysis issues.
Dealing with missing data
There were nomissing data.We contacted study authors if the data
could not be extrapolated in the desired form from the published
manuscript.
Assessment of heterogeneity
In a random-effects model, the overall effects are adjusted to in-
clude an estimate of the degree of variation between studies, or het-
erogeneity, in intervention effect (Tau2) (Deeks 2011). The Chi
2 test assesses whether the differences in results are beyond those
that can be attributed to sampling error (chance). The impact of
heterogeneity on the meta-analysis results is quantified by the I
2 statistic. This statistic describes the percentage of variability in
the effect estimates that is due to heterogeneity rather than chance
(Deeks 2011); 30% to 60% probably represents moderate hetero-
geneity while greater than 50% is usually considered as represent-
ing substantial heterogeneity.
Assessment of reporting biases
For studies published after 1 July 2005, we screened the Clinical
Trial Register at the International Clinical Trials Registry Platform
of the World Health Organization (apps.who.int/trialssearch) for
the a priori trial protocol.We evaluatedwhether selective reporting
of outcomes is present (outcome reporting bias).
To assess for potential small-study effects in meta-analyses (i.e.
the intervention effect is more beneficial in smaller studies), we
compared effect estimates derived from a random-effects model
and a fixed-effect model of meta-analysis. In the presence of small-
study effects, the random-effects model will give a more beneficial
estimate of the intervention than the fixed-effect estimate (Sterne
2011).
Data synthesis
We used the random-effects model to combine outcomes.
’Summary of findings’ table
We created a ’Summary of findings’ table using the following out-
comes: pain, self reported physical function and adverse events,
and also quality of life and withdrawals for the immediate post
treatment time point.We assessed the quality of the evidence using
the five GRADE considerations (study limitations, consistency of
effect, imprecision, indirectness and publication bias) to assess the
quality of a body of evidence for the outcomes using GRADEpro
software (Schünemann 2011a; Schünemann 2011b).
Outcomes pooled using SMDwere re-expressed as absolute mean
difference using a representative control group baseline SD from
a trial using a familiar instrument and dividing by the points of
the measurement scale and expressed as a percentage.
In the comments column of the ’Summary of findings’ table, we
have presented the absolute per cent difference, the relative per
cent change from baseline and the number needed to treat for an
additional beneficial outcome (NNTB), or an additional harmful
outcome (NNTH) (the number needed to treat (NNT) is only
provided for outcomes with statistically significant differences be-
tween the intervention and control groups).
For dichotomous outcomes, the absolute risk difference was cal-
culated using the risk difference statistic in Review Manager 5
(RevMan 2012) and the result expressed as a percentage; the rela-
tive percentage change was calculated as the risk ratio -1 and was
expressed as a percentage; and the NNT from the control group
event rate and the risk ratio were determined using the Visual Rx
NNT calculator (Cates 2008).
For continuous outcomes, the absolute risk difference was cal-
culated as the mean difference between intervention and control
groups in the original measurement units (divided by the scale),
expressed as a percentage; the relative difference was calculated as
the absolute change (or mean difference) divided by the baseline
mean of the control group from a representative trial. We used
theWells calculator to obtain the NNTB for continuous measures
(available at the Cochrane Musculoskeletal Group (CMSG) Ed-
itorial office; musculoskeletal.cochrane.org/). The minimal clini-
cally important difference (MCID) for each outcome was deter-
mined for input into the calculator. We assumed an MCID of 15
points on a 0- to 100-point pain scale; and 10 points on a 0- to
100-point function scale.
Subgroup analysis and investigation of heterogeneity
We evaluated the influence of using end of treatment or change
scores for the investigation of heterogeneity.
Sensitivity analysis
To evaluate potential exercise programme targeting, we conducted
a sensitivity analysis to assess the impact of recruiting solely par-
ticipants with hip OA compared with recruiting participants with
hip or knee OA.
R E S U L T S
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Description of studies
Of the 44 retrieved RCTs identified from the literature search
(Figure 1), 10met the inclusion criteria (van Baar 1998; Hopman-
Rock 2000; Foley 2003;Tak 2005; Fransen 2007; Fernandes 2010;
Carlson 2011; Juhakoski 2011; Abbott 2013; French 2013) and
are detailed in the Characteristics of included studies table. Of the
10 studies, only five recruited solely participants with symptomatic
hip OA (Tak 2005; Fernandes 2010; Carlson 2011; Juhakoski
2011; French 2013). The other five studies recruited participants
with either hipOAor kneeOA, or both. These five RCTs provided
data specific for the participants indicating the hip joint as either
the only symptomatic joint or themost symptomatic (signal) joint
for pain reporting. Two studies included three allocations, each
having a land-based exercise allocation (gym-based classes (Foley
2003) or Tai Chi classes (Fransen 2007), a hydrotherapy allocation
and a waiting list control group. For the current meta-analysis,
the land-based exercise allocation was compared with the waiting
list control group. Two further studies had an exercise allocation
(individual treatments) in addition to an allocation to exercise plus
manual therapy (Abbott 2013; French 2013). For these two stud-
ies, the exercise (alone) allocation was compared with the waiting
list or usual care control group.
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Figure 1. Study flow diagram.
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We excluded 34 studies for reasons provided in the Characteristics
of excluded studies table (Figure 1).
Only two RCTs had more than 50 participants in each allocation
group (Fernandes 2010; Juhakoski 2011).
There was large variability in treatment dosage. Four studies pro-
vided fewer than 10 supervised sessions (Hopman-Rock 2000; Tak
2005; Abbott 2013; French 2013). Five studies provided access to
at least 16 sessions. Six of the 10 RCTs evaluated class-based pro-
grammes, while the other four studies provided treatments as indi-
vidual sessions with a physiotherapist (van Baar 1998; Fernandes
2010; Abbott 2013; French 2013). While one RCT evaluated a
specific ’Tai Chi for Arthritis’ programme (Fransen 2007), the
other studies evaluated more traditional muscle strengthening,
functional training and aerobic fitness programmes.
Sample recruitment varied widely. Four RCTs recruited commu-
nity volunteers (Hopman-Rock 2000; Tak 2005; Fransen 2007;
Juhakoski 2011), one RCT recruited participants through general
practice (van Baar 1998), and four recruited mostly through spe-
cialist clinics (Foley 2003; Carlson 2011; Abbott 2013; French
2013). The variability in recruitment strategies resulted in marked
differences in study participant samples. Approximately 50% of
participants in one RCT reported a symptom duration of less than
one year (van Baar 1998), while another RCT included a large
proportion (40%) of participants who were already on the or-
thopaedic surgery waiting list (Foley 2003).
Seven included RCTs used theWOMAC to evaluate pain or phys-
ical function, or both (Foley 2003; Fransen 2007; Fernandes 2010;
Carlson 2011; Juhakoski 2011; Abbott 2013; French 2013). One
study used a numerical rating scale to evaluate pain (with activ-
ity), while using the WOMAC subscale to evaluate physical func-
tion (French 2013). The other three studies, all conducted in The
Netherlands, used a 10-cm visual analogue scale (VAS) to evaluate
hip pain and either the Influence of Rheumatic Diseases on Gen-
eral Health and Lifestyle (IRGL) questionnaire (van Baar 1998;
Hopman-Rock 2000) or the Groningen Activity Restriction Scale
(GARS) (Tak 2005) to evaluate physical function. The GARS
measures level of disability performing 18 daily activities with a
score ranging from 18 (no problems) to 72 (only with help from
others).
For pain and physical function, nine RCTs provided immediate
post-treatment outcomes assessments, while five RCTs evaluated
treatment sustainability three to sixmonths after completion of the
supervised exercise programme. Only five RCTs provided quality
of life assessments (Hopman-Rock 2000; Foley 2003; Tak 2005;
Fransen 2007; French 2013). Data specific for participants with
hipOAcould only be provided by three studies (Tak 2005; Fransen
2007; French 2013). Two of these studies provided the popula-
tion-based SF-12 MCS scores as an indicator of quality of life
(Fransen 2007; French 2013), while one study used a generic 0 to
10 VAS scale (Tak 2005). Quality of life data, specific for hip OA
participants, were not available from two older studies reported in
the original review (Hopman-Rock 2000; Foley 2003).
Risk of bias in included studies
One RCT was only reported as a conference abstract with insuf-
ficient information to evaluate risk of bias criteria (Carlson 2011)
(Figure 2).
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
We considered seven of the 10 included RCTs as ’low risk of bias’
for allocation concealment (van Baar 1998; Foley 2003; Fransen
2007; Fernandes 2010; Juhakoski 2011; Abbott 2013; French
2013), while three had ’uncertain risk’ (Hopman-Rock 2000; Tak
2005; Carlson 2011), as no specific information was provided
(Figure 2).
Blinding
None of the included RCTs was able to blind participants or per-
sonnel (therapists providing the interventions) to treatment allo-
cation (Figure 2).
While all of the included RCTs reported blinding of outcomes
assessor, the outcomes (pain, physical function, quality of life)
were participant reported and results may, therefore, be vulnerable
to detection bias.
Incomplete outcome data
Eight of the 10 included RCTs had only minimal loss to follow-
up or used intention-to-treat analysis.
Selective reporting
Only four of the 10 included RCTs indicated evidence of study
registration.
Other potential sources of bias
There were three studies with unclear risk of other biases: lengthy
period (eight months) between end of supervised treatment pro-
gramme and outcomes assessment (Abbott 2013); abstract only
so minimal information on study methodology (Carlson 2011);
40% of participants on the orthopaedic surgery waiting list (Foley
2003).
Effects of interventions
See: Summary of findings for the main comparison Immediate
post-treatment effect of exercise for osteoarthritis of the hip;
Summary of findings 2 Sustainability (three to six months) for
osteoarthritis of the hip
We contacted four study authors to provide data specific for OA
hip for pain and physical function outcomes (van Baar 1998;
Hopman-Rock 2000; Foley 2003; Abbott 2013). All four re-
sponded with the requested data. We were unable to contact the
authors of one included pilot study that had been published as an
abstract (Carlson 2011).
Immediate post treatment
Pain
Nine of the 10 includedRCTs provided immediate post-treatment
effects on 549 participants.
Combining the results demonstrated a significant benefit (SMD
(random-effects model) -0.38, 95% CI -0.55 to -0.20; Figure 3).
This effect size would be considered small to moderate (Cohen
1977). Between-study heterogeneity was negligible (I2 = 0%). The
demonstrated effect size for exercise was equivalent to a pain re-
duction of 8 points (95%CI 4 to 11) on a 0 to 100 scale compared
with a control group.
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Figure 3. Forest plot of comparison: 1.1 Pain.
Physical function
Nine of the 10 includedRCTs provided immediate post-treatment
effects on 521 participants.
Combining the results demonstrated a significant benefit (SMD
-0.30, 95% CI -0.54 to -0.05; Figure 4). Between-study hetero-
geneity was moderate (I2 = 41%). Limiting pooling to the six
RCTs providing post-treatment scores, rather than change scores,
resulted in a similar benefit (SMD -0.33, 95% CI -0.53 to -
0.13) and reduced between-study heterogeneity to 0%. This effect
size would be considered small to moderate (Cohen 1977). The
demonstrated effect size for exercise was equivalent to an improve-
ment of physical function of 7 points (95% CI 1 to 12) on a 0 to
100 scale compared with a control group.
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Figure 4. Forest plot of comparison: 1.2 Physical function.
Quality of life
Only three of the 10 includedRCTs could provide immediate post-
treatment effects on 183 participants with hip OA. A higher score
is a better score. Two studies used population norm-based scores
with a mean of 50 (SD 10). No significant difference was detected
(SMD 0.10, 95% CI -0.23 to 0.36). Between-study heterogeneity
was negligible (I2 = 0%).
Study withdrawals
Only seven studies provided data on study withdrawals at the time
of the first post-treatment assessment. Of these seven studies, only
whole sample estimates (knee and hip OA) were available for two
studies (van Baar 1998; Foley 2003). There was no significantly
increased risk of study withdrawal from the exercise allocation
(6.3%) compared with the control group (3.4%) (Risk difference
0.01, 95% CI -0.01 to 0.04); Analysis 1.4).
Treatment sustainability (three to six months)
Pain
Five of the 10 included RCTs provided treatment sustainability
pain outcomes on391participants. Combining the results demon-
strated a significant benefit (SMD -0.38, 95% CI -0.58 to -0.18;
Figure 5). Between-study heterogeneity was negligible (I2 = 0%).
This effect size would be considered small to moderate (Cohen
1977).
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Figure 5. Sustainability (three to six months), outcome: 2.1 Pain.
Physical function
Five of the 10 included RCTs provided treatment sustainability
physical function outcomes on 365 participants. Combining the
results demonstrated a significant benefit (SMD -0.37, -0.57 to
-0.16; Figure 6). Between-study heterogeneity was negligible (I2
= 0%). This effect size would be considered small to moderate
(Cohen 1977).
Figure 6. 2 Sustainability (three to six months), outcome: 2.2 Physical function.
Studies recruiting only participants with hip
osteoarthritis compared with studies recruiting
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participants with hip and knee osteoarthritis
Pain
Combining the results of the five studies (419 participants) recruit-
ing solely people with hip OA demonstrated a significant benefit
(SMD -0.30, 95% CI -0.49 to -0.10). Combining the results of
the four studies (130 participants) recruiting people with either
hip or knee OA demonstrated a larger mean benefit (SMD -0.66,
95% CI -1.02 to -0.29). There was no significant difference be-
tween the two groups of studies (P value = 0.09).
Physical function
Combining the results of the five studies (393 participants) recruit-
ing solely people with hip OA demonstrated a significant benefit
(SMD -0.35, 95% CI -0.57 to -0.13). Combining the results of
the four studies (128 participants) recruiting people with either
hip or knee OA did not detect a significant benefit (SMD -0.20,
95% CI -0.79 to 0.40). There was no significant difference be-
tween the two groups of studies (P value = 0.64). Between-study
heterogeneitywas substantial for the studies recruiting participants
with either hip or knee OA (I2 = 54%).
Adverse events
Only five RCTs specifically reported adverse events (van Baar
1998; Foley 2003; Tak 2005; Fransen 2007; Abbott 2013).
Abbott 2013 “detected no trial related adverse events”, van Baar
1998 stated one patient receiving exercise reported adverse effects;
Tak 2005 reported two participants in the exercise groupwithdrew
due to increased back pain; Foley 2003 reported four withdrawals
in the exercise group due to increased pain (two people), increased
blood pressure (one person) and doctor’s advice (one person) com-
pared with one withdrawal due to illness in the control group; and
Fransen 2007 reported only withdrawals in the Tai Chi allocation
among participants with knee OA.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Sustainability (3-6 months) for osteoarthritis of the hip
Patient or population: people with osteoarthritis of the hip
Settings:
Intervention: sustainability (3-6 months)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Sustainability (3-6
months)
Pain
Follow-up: 3-6 months
The mean pain ranged
across control groups
from
5 points on a 0-10 scale
to 29 points on a 0-100
scale
The mean pain in the in-
tervention groups was
0.38 standard deviations
lower
(0.58 to 0.18 lower)
This translates to an ab-
solute mean reduction 8
(4 to 12) points compared
with control group using
a 0-100 scale
- 391
(6 studies)
⊕⊕⊕⊕
high
SMD -0.38 (-0.58 to -0.
18)
Absolute change 8 (4 to
12) points on a 0-100
scale
Physical Function
Follow-up: 3-6 months
The mean physical func-
tion ranged across con-
trol groups from
24 points on a 0-100
scale to 59 points on a
0-170 scale
The mean physical func-
tion in the intervention
groups was
0.37 standard deviations
lower
(0.57 to 0.16 lower)
This translates to an ab-
solute mean reduction 7
(4 to 13) points compared
with control group using
a 0-100 scale
- 365
(6 studies)
⊕⊕⊕⊕
high
SMD -0.37 (-0.57 to -0.
16)
Absolute change 7 (4 to
13) points on a 0-100
scale
1
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Adverse events
not reported
See comment See comment Not estimable - See comment No adverse events such
as injuries were reported
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; NNTB: number needed to treat for an additional beneficial outcome
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
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D I S C U S S I O N
Summary of main results
The objective of this systematic review was to evaluate the cur-
rent scientific evidence for the benefit of land-based exercise for
people with symptomatic hip OA in terms of joint pain, self re-
ported physical function and quality of life. The overall results
of the meta-analysis suggest that land-based exercise is beneficial
in terms of reduced pain and improved physical function at the
completion of a supervised exercise programme and these benefits
are sustained for at least a further three to six months. There was
insufficient evidence available to determine the effect of exercise
on quality of life among people with hip OA. The level of pain was
generally mild to moderate at baseline and thus although the re-
duction in pain in favour of exercise was potentially small (a mean
absolute change of 8%), a mean relative change of 28% (38% for
the upper limit) could be considered clinically important for a low-
risk intervention such as exercise. Similarly for physical function,
a relative change of 42% could not be ruled out.
Overall completeness and applicability of
evidence
The meta-analysis could include 10 small RCTs. There were
marked differences between these RCTs in the content and dura-
tion of the exercise programmes provided and in the participant
samples recruited. Only one of the larger RCTs demonstrated sig-
nificant benefits in both pain and physical function at the end
of the treatment programme (French 2013). This study provided
only eight weekly sessions of individually supervised exercise ses-
sions but also prescribed a daily home programme of 30 minutes
of walking, cycling or swimming. One other study demonstrated
significant benefit in terms of pain only (van Baar 1998). The
participants in this study were referrals from general practice with
mostly very early symptomatic disease (less than one year). The
two largest RCTs were the only studies to demonstrate significant
sustainable benefit at three to six months for physical function
(Fernandes 2010; Juhakoski 2011). The first provided 24 indi-
vidual sessions with a physiotherapist over 12 weeks (Fernandes
2010). The exercise programme had a mixed content of muscle
strengthening and functional exercise. The second provided 16
sessions of high-intensity muscle strengthening (Juhakoski 2011).
It is notable that these three RCTs demonstrating significant bene-
fits were among the five RCTs that restricted recruitment to people
with hip OA. Of the other two RCTs restricting recruitment to
only participants with hipOA, one had amuch smaller sample size
(Tak 2005), and the other did not evaluate long-term outcomes
(Carlson 2011). It is likely that their exercise programmes were,
therefore, more specific to this condition compared to RCTs that
recruited both people with knee, hip or both knee and hip OA.
This concern would be particular for hip OA as the proportion of
participants with hipOA in these combined programmes is always
much smaller than the proportion with knee OA. The proportion
of RCTs restricting recruitment to people with hip OA was much
higher for this update (5/10 studies), compared with the previous
review (1/5 studies), and may explain the shift to finding signifi-
cant improvement for physical function in the current update.
It would be worthwhile if future studies explore the effect of more
intensive lower limb muscle strengthening programmes further
and provide more information regarding exercise adherence or the
effect of strategies to improve exercise adherence in this popula-
tion.We have still only been able to include five studies specifically
targeting people with hip OA. Exercise covers a very broad area, so
the potential for development of more beneficial and sustainable
exercise protocols is evident. A larger number of studies would al-
low for meaningful subgroup analyses on basis of exercise content
and dosage.
Quality of the evidence
Most of the RCTs included in this systematic review were con-
sidered by our criteria to have a ’low risk of bias’. While all the
RCTs reported having blinded outcome assessment, participants
were aware of their allocation status. Given that the main out-
comes of this review were participant self reported pain and phys-
ical function, there is a possibility that the treatment effect sizes
may be inflated. Given the difficulty blinding participants to exer-
cise treatment allocation (versus no exercise) and the high quality
of the evidence for pain and physical function benefit, we expect
that new studies would not change our confidence in the effect
estimates.
The quality of the body of evidence was high for pain and func-
tion. Although there may be a potential study limitation for the
evidence for pain and function (a potential for bias that may over-
estimate the effect sizes), we did not consider that it was substantial
enough to downgrade the evidence. The evidence underpinning
quality of life was low overall due to the limited number (three) of
small studies evaluating this outcome. Further, quality of life does
not appear to be influenced bymild-to-moderate symptomatic hip
OA as the quality of life assessment reported in the two studies
using the SF-MCS was in line with published population-based
normative values. The evidence for withdrawals was moderate due
to unspecific reporting. Many studies simply reported the number
of participants attending outcomes assessments, and did not pro-
vide quantitative data regarding the number of participants with-
drawing from study treatment.
Potential biases in the review process
We expect minimal biases in extracting and reporting of data (four
review authors selected studies for inclusion, two review authors
independently extracted data). We conducted an extensive liter-
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ature search. However, the possibility of publication bias could
not be ruled out, as we did not attempt to retrieve unpublished
studies.
Agreements and disagreements with other
studies or reviews
The mean effect size for immediate post-treatment hip pain re-
ported in this meta-analysis were similar to those reported in a
previous meta-analysis (SMD -0.38) (Hernandez-Molina 2008).
The previousmeta-analysis included five RCTs from1998 to 2007
included in this review, but also included three further RCTs eval-
uating hydrotherapy, as well as the hydrotherapy results of two
included RCTs (Foley 2003; Fransen 2007). While the mean ef-
fect size was identical, the CIs around the estimate were much
wider (95% CI 0.08 to 0.68) than those demonstrated in the cur-
rent review (95% CI 0.20 to 0.55). The original Cochrane review,
“Exercise for osteoarthritis of the hip” (Fransen 2009), could only
pool the findings of five RCTs with 204 participants. This pre-
vious review did not demonstrate a significant benefit in terms
of pain and physical function. Marked heterogeneity was evident
and only one of the five RCTs restricted recruitment to people
with hip OA (Tak 2005). In the current review, about 75% of
study participants were enrolled in RCTs restricting recruitment
to people with hip OA.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is currently high-level evidence that land-based exercise will
reduce hip pain (van Baar 1998; French 2013), and improve phys-
ical function (Fernandes 2010; Juhakoski 2011; French 2013),
among people with symptomatic hip osteoarthritis.
Implications for research
Identify possible predictors of treatment responsiveness and exer-
cise adherence in this population.
Developmulti-armed randomised controlled trials to help provide
evidence of optimal exercise content and dosage. Initiate research
to assess the long-term effectiveness of exercise for people with
hip osteoarthritis in terms of disease progression and time to joint
replacement surgery.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Abbott 2013
Methods Low bias risk
Blinded assessor
ITT analysis
Usual GP care control group
Participants People with hip and knee OA
4-arm RCT: manual therapy, exercise therapy, manual therapy plus exercise therapy,
usual GP care alone
45 people with hip OA allocated to exercise or usual GP care alone groups
Mean age: 66 years
ACR clinical criteria
Interventions Individually provided by physiotherapy, 50minutes (7 weeks, 1 x per week plus 2 booster
sessions week 16)
Control: usual GP care alone
Outcomes At 1 year:
WOMAC pain (0-50)
WOMAC physical function (0-170)
Notes Long interval between end of monitored treatment (4 months) and outcomes assessment
(1 year)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation centre used
Allocation concealment (selection bias) Low risk Randomisation centre used
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Physiotherapists and participants aware of
treatment allocation
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Blinded outcomes assessor, but participant
self reported pain and function
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT and minimal loss to follow-up (maxi-
mum: 2/51 exercise; 4/51 usual care)
Selective reporting (reporting bias) Low risk Registered trial protocol
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Abbott 2013 (Continued)
Other bias Unclear risk 8-month interval between end of moni-
tored treatment and outcomes assessment
Carlson 2011
Methods Unclear risk of bias
Participants Hip only
Recruited from specialist clinics and the community
Pain at least once per week in 1 or both hips, difficulty with ADL secondary to hip pain,
radiographic evidence of femoral or acetabular osteophytes (or both) or axial joint space
narrowing and active hip flexion < 115 degrees
Interventions 20 people allocated to 3 month aerobic activity and resistance training programme (45
minutes) 2-3 times per week, 10 people to usual care
Outcomes Post treatment only
Pain on 0-100 VAS
WOMAC physical function (0-100)
Notes No response to email request for further information
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Abstract only - no information provided
Allocation concealment (selection bias) Unclear risk Abstract only - no information provided
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel aware of treatment allocation
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Abstract only - no information provided
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Abstract only - no information provided
Selective reporting (reporting bias) Unclear risk Abstract only - no information provided
Other bias Unclear risk None apparent
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Fernandes 2010
Methods Low bias risk
Blinded assessor
No loss to follow-up at 4 months
Patient education only control (’Hip School’)
Participants *Hip OA only
109 people with hip pain > 3 months and HHS 60-95
Mean age 58 years
Radiographic criteria: joint space width < 4 mm
Interventions Individually based, clinic 12 weeks (2 x per week)
Treatment: mixed - strengthening, functional, flexibility
Outcomes At 4 months:
WOMAC Pain (0-100)
WOMAC Physical Function (0-100)
Notes About 20% loss to follow-up at 10 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated, blocks of 10
Allocation concealment (selection bias) Low risk Independent researcher, sealed numbered
envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Physiotherapists and participants aware of
treatment allocation
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Blinded outcomes assessor, but participant
self reported pain and function
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 1person lost to follow-up at 4months
(20 people lost at 10 months)
Selective reporting (reporting bias) Low risk Main outcomes specified a priori -
WOMAC pain
Other bias Low risk None apparent
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Foley 2003
Methods Low bias risk
Blinded assessor
ITT analysis
Waiting list
Participants People with hip and knee OA recruited
29 mostly clinic patients with hip OA
Mean age: 70 years
Radiographic criteria
Interventions Class-based (6 weeks)
Treatment: 18 x strengthening, ROM, 30-minute classes
Control: telephone call every 2 weeks
Outcomes At 6 weeks:
WOMAC pain (0-20)
WOMAC function (0-68)
Unable to obtain SF-12 MCS data specific for people with hip OA for the updated
review
Notes Separate analysis per hip OA, gym-based group vs. controls
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Central allocation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel aware of treat-
ment allocation
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Blinded outcomes assessor, but participant
self reported pain and function
Incomplete outcome data (attrition bias)
All outcomes
Low risk Small numbers lost to follow-up, balanced
between allocation groups
Selective reporting (reporting bias) Unclear risk Unable to ascertain
Other bias Unclear risk About 40% on orthopaedic waiting list
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Fransen 2007
Methods Low bias risk
Blinded assessor
ITT analysis
Waiting list
Participants People with hip and knee OA recruited
20 community volunteers hip OA
75% female
Mean age: 70 years
ACR criteria
Interventions Class-based (12 weeks)
Treatment: 24 x tai chi classes, 60-minute classes
Control: waiting list
Outcomes At 12 weeks:
WOMAC pain (0-100)
WOMAC function (0-100)
SF-MCS
Notes Disaggregated analysis (hip or knee OA) according to identified signal (most painful)
joint
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random numbers table
Allocation concealment (selection bias) Low risk Central allocation by administrator
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel aware of treat-
ment allocation
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Blinded outcomes assessor, but participant
self reported pain and function
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis
Selective reporting (reporting bias) Low risk Trial registered NCT00123994
Other bias Low risk None apparent
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French 2013
Methods Low risk bias
Blind assessor
ITT analysis
Waiting list control
Participants *Hip OA only recruited (ACR clinical and radiographic criteria)
88 people (exercise or control) referred for physiotherapy by GPs or hospital consultants
Mean age: 65 years
Interventions Individually provided ’standardised’ exercise programme (8 x 30-minute sessions over
8 weeks) plus daily home exercise programme (aerobic walking/cycling/swimming 30
minutes)
Treatment: strengthening, flexibility, aerobic
Outcomes At 9 weeks:
Pain on activity (0-10 NRS)
WOMAC Physical Function (0-68)
SF-12 MCS
Notes Low-intensity programme - 8 x 30 minutes monitored only. Unclear why WOMAC
pain not used as primary outcome
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated sequence
Allocation concealment (selection bias) Low risk Off-site randomisation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel aware of treat-
ment allocation
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Blinded outcomes assessor, but participant
self reported pain and function
Incomplete outcome data (attrition bias)
All outcomes
Low risk Multiple imputations, only 3 people lost to
follow-up at 9 weeks
Selective reporting (reporting bias) Low risk Protocol published
Other bias Low risk None apparent
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Hopman-Rock 2000
Methods Moderate bias risk
Blind assessor
Efficacy analysis
Waiting list
Participants Hip and knee OA recruited (ACR criteria)
28 volunteers hip OA, 80% female
Mean age: 65 years
Interventions Class-based (6 weeks)
Treatment: 6 x education + exercise, 60-minute classes
Outcomes At 6 weeks:
VAS pain (2)
IRGL mobility (7-28)
Unable to obtain quality of life data specific for people with hip OA for the updated
review
Notes Short programme. Only 6 supervised treatment occasions
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel aware of treat-
ment allocation
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Blinded outcomes assessor, but participant
self reported pain and function
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Efficacy analysis
Selective reporting (reporting bias) Unclear risk Insufficient information
Other bias Low risk None apparent
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Juhakoski 2011
Methods Low bias risk
Blinded assessor
ITT analysis
GP care control group
Participants *Hip OA only
Community volunteers
Mean age: 66 years
About 80% overweight or obese
ACR clinical criteria
K&L 1-2 (85%)
Interventions Exercise and GP care
Class-based (12 weeks) 45 minutes x 12 weekly sessions + 4 booster sessions 1 year later
Strengthening (with maximal effort)
Outcomes 3 months/6 months
WOMAC Pain (0-100)
WOMAC Physical Function (0-100)
Notes Both groups access to physiotherapy (as part of GP care); however, only mean sum of
visits over 24 months of 1.3 (active group) vs. 2.0 (control group). WOMAC scores
’adjusted’ for baseline differences in outcome measures, age, gender, radiological score,
comorbidities, existence of kneeOAor knee pain (or both) and duration of hip symptoms
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Sealed envelopes, offsite randomisation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel aware of treat-
ment allocation
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Blinded outcomes assessor, but participant
self reported pain and function
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT, last observation carried forward, min-
imal loss to follow-up (2 people at 3
months)
Selective reporting (reporting bias) Unclear risk Not registered
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Juhakoski 2011 (Continued)
Other bias Low risk None apparent
Tak 2005
Methods Moderate bias risk
Blinded assessor
Efficacy analysis
Waiting list
Participants *Hip OA only
109 community volunteers
Mean age: 68 years
Clinical ACR criteria
Clinical criteria OA hip
Interventions Class-based (8 weeks)
Treatment: 8 x strengthening + home programme, 60-minute classes
Outcomes At 8 weeks:
VAS pain (0-10)
GARS function (18-72)
Generic quality of life (0-10)
Notes Short programme. Only 8 supervised treatment sessions
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated table
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel aware of treat-
ment allocation
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Blinded outcomes assessor, but participant
self reported pain and function
Incomplete outcome data (attrition bias)
All outcomes
High risk Efficacy analysis, 36% and 28% missing
data for pain outcome
Selective reporting (reporting bias) Unclear risk Not registered
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Tak 2005 (Continued)
Other bias Low risk None apparent
van Baar 1998
Methods Low bias risk
Blinded assessor
ITT analysis
Control: GP education
Participants Hip and knee OA recruited
81 people from GP clinic with hip OA
79% female
Mean age: 68 years
ACR criteria
Interventions Individual programme (12 weeks)
Treatment: 17 x physiotherapy (30-minute sessions) + GP education
Outcomes At 12 weeks:
Pain (VAS x 1) (0-100)
Function IRGL (7-28)
Notes Separate results provided for hip OA. Mostly early disease as approximately 50% sample
had symptom duration < 1 year
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random numbers table
Allocation concealment (selection bias) Low risk Sealed opaque envelopes, sequential num-
bering for audit trail
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel aware of treat-
ment allocation
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Blinded outcomes assessor, but participant
self reported pain and function
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis
Selective reporting (reporting bias) Unclear risk Not registered
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van Baar 1998 (Continued)
Other bias Low risk None apparent
ACR: American College of Rheumatology; ADL: activities of daily living; GARS: Groningen Activity Restriction Scale; GP: general
practitioner; HHS: Harris Hip Score; IRGL: Influence of Rheumatic Diseases on General Health and Lifestyle; ITT: intention to
treat; K&L: Kellgren and Lawrence; MCS: Mental Component Summary; NRS: Numerical Rating Scale; OA: osteoarthritis; RCT:
randomised controlled trial; ROM: range of motion; SF: Short Form; SF-12: 12-item Short Form; WOMAC: Western Ontario and
McMaster Universities Osteoarthritis Index; VAS: visual analogue scale.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abbott 2012 Health economic evaluation only, abstract
Angst 2001 No control group
Boeer 2010 No non-exercise group, all participated in ’Hip School’
Brantingham 2012 No non-exercise group. RCT comparing 2 different manual and manipulative therapy techniques in addition
to exercise
Cochrane 2005 No land-based exercise group
Coupe 2007 Supplementary analysis Veenhof 2006
de Jong 2004 No non-exercise control group
Eitzen 2011 Supplementary analysis Fernandes 2010. Predictive study using gait characteristics
Green 1993 No appropriate control. Assessed added benefit of hydrotherapy to home exercises
Halbert 2001 Physical activity advice/recommendation only
Haslam 2001 Advice and exercise was the control group
The evaluated treatment was acupuncture
Heuts 2005 Arthritis self management education programme with no supervised exercise sessions
Hinman 2007 No land-based exercise group
Hoeksma 2004 No non-exercise control. Manual therapy vs. exercise
Hoeksma 2005 Supplementary analysis of Hoeksma 2004
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(Continued)
Hoeksma 2006 Supplementary analysis of Hoeksma 2004
Klasbo 2003 Education sessions with on therapeutic exercise advice
Koybashi 2010 No non-exercise control
Lin 2004 No land-based exercise group
Pisters 2010a No non-exercise group. Both treatment allocation were supervised by physiotherapists and involved exercise-
focused programmes
Pisters 2010b No non-exercise group. Both treatment allocation were supervised by physiotherapists and involved exercise-
focused programmes
Ravaud 2004 Cluster randomised trial, unsupervised exercise and all participants prescribed daily Vioxx
Rooks 2006 Peri-operative exercise programme
Song 2010 Suspect focus on people with knee osteoarthritis; however, site of symptomatic osteoarthritis not specified
Steenstrup 2012 Limited exercise involved (only 10 x a single hip abduction exercise). The physiotherapy involved mostly
manual therapy plus electrotherapy
Steinhilber 2012 Included people with total hip replacement
Stener-Victoria 2004 No land-based exercise group
Svege 2010 Supplementary analysis of Fernandes 2010
Svege 2011 Supplementary analysis of Fernandes 2010
Sylvester 1989 No appropriate control. Hydrotherapy compared with exercises plus shortwave diathermy (14 people)
Uesugi 2012 Evaluating 2 delivery modes (DVD or written materials) of same exercise programme
van Baar 2001 Secondary analysis van Baar 1998 (follow-up study)
Veenhof 2006 No non-exercise control. Both treatment allocations (behavioural graded activity or usual physiotherapy care)
were supervised by physiotherapists and involved exercise-focused programmes
Wang 2007 No land-based exercise group
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D A T A A N D A N A L Y S E S
Comparison 1. Immediate post treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain 9 549 Std. Mean Difference (IV, Random, 95% CI) -0.38 [-0.55, -0.20]
1.1 End of treatment scores 8 519 Std. Mean Difference (IV, Random, 95% CI) -0.38 [-0.55, -0.20]
1.2 Change scores 1 30 Std. Mean Difference (IV, Random, 95% CI) -0.36 [-1.12, 0.41]
2 Physical function 9 521 Std. Mean Difference (IV, Random, 95% CI) -0.30 [-0.54, -0.05]
2.1 End of treatment scores 6 401 Std. Mean Difference (IV, Random, 95% CI) -0.33 [-0.53, -0.13]
2.2 Change scores 3 120 Std. Mean Difference (IV, Random, 95% CI) -0.20 [-0.96, 0.55]
3 Quality of life 3 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
3.1 End of treatment scores 3 183 Std. Mean Difference (IV, Random, 95% CI) 0.07 [-0.23, 0.36]
4 Study withdrawals 7 715 Risk Difference (M-H, Random, 95% CI) 0.01 [-0.01, 0.04]
Comparison 2. Sustainability (three to six months)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain 5 391 Std. Mean Difference (IV, Random, 95% CI) -0.38 [-0.58, -0.18]
1.1 End of treatment 4 326 Std. Mean Difference (IV, Random, 95% CI) -0.39 [-0.61, -0.17]
1.2 Change scores 1 65 Std. Mean Difference (IV, Random, 95% CI) -0.34 [-0.83, 0.15]
2 Physical function 5 365 Std. Mean Difference (IV, Random, 95% CI) -0.37 [-0.57, -0.16]
2.1 End of treatment 4 300 Std. Mean Difference (IV, Random, 95% CI) -0.43 [-0.66, -0.20]
2.2 Change scores 1 65 Std. Mean Difference (IV, Random, 95% CI) -0.07 [-0.56, 0.42]
Comparison 3. Hip osteoarthritis (OA) versus hip/knee OA studies
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain post treatment 9 549 Std. Mean Difference (IV, Random, 95% CI) -0.38 [-0.55, -0.20]
1.1 Hip OA only 5 419 Std. Mean Difference (IV, Random, 95% CI) -0.30 [-0.49, -0.10]
1.2 Hip/knee OA 4 130 Std. Mean Difference (IV, Random, 95% CI) -0.66 [-1.02, -0.29]
2 Physical function post treatment 9 521 Std. Mean Difference (IV, Random, 95% CI) -0.30 [-0.54, -0.05]
2.1 Hip OA only 5 393 Std. Mean Difference (IV, Random, 95% CI) -0.35 [-0.57, -0.13]
2.2 Hip/knee OA 4 128 Std. Mean Difference (IV, Random, 95% CI) -0.20 [-0.79, 0.40]
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Analysis 1.1. Comparison 1 Immediate post treatment, Outcome 1 Pain.
Review: Exercise for osteoarthritis of the hip
Comparison: 1 Immediate post treatment
Outcome: 1 Pain
Study or subgroup Exercise Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 End of treatment scores
van Baar 1998 35 26 (25.85) 33 43.42 (21.61) 12.1 % -0.72 [ -1.21, -0.23 ]
Hopman-Rock 2000 11 37 (26) 13 47.2 (20.5) 4.4 % -0.43 [ -1.24, 0.39 ]
Foley 2003 6 9 (3.58) 12 10.58 (4.12) 3.0 % -0.38 [ -1.37, 0.61 ]
Tak 2005 35 3.6 (2.5) 39 4.1 (2.1) 14.0 % -0.22 [ -0.67, 0.24 ]
Fransen 2007 15 5.57 (3.18) 5 9.2 (3.35) 2.5 % -1.08 [ -2.16, 0.00 ]
Fernandes 2010 55 20.6 (17.21) 54 25.3 (18.5) 20.6 % -0.26 [ -0.64, 0.12 ]
Juhakoski 2011 60 24.1 (21.7) 58 27.8 (19.8) 22.4 % -0.18 [ -0.54, 0.18 ]
French 2013 45 4.02 (2.88) 43 5.62 (2.84) 16.1 % -0.55 [ -0.98, -0.13 ]
Subtotal (95% CI) 262 257 95.0 % -0.38 [ -0.55, -0.20 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 6.21, df = 7 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 4.20 (P = 0.000027)
2 Change scores
Carlson 2011 20 -9.3 (15) 10 -4.2 (11) 5.0 % -0.36 [ -1.12, 0.41 ]
Subtotal (95% CI) 20 10 5.0 % -0.36 [ -1.12, 0.41 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.92 (P = 0.36)
Total (95% CI) 282 267 100.0 % -0.38 [ -0.55, -0.20 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 6.21, df = 8 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 4.30 (P = 0.000017)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.97), I2 =0.0%
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Analysis 1.2. Comparison 1 Immediate post treatment, Outcome 2 Physical function.
Review: Exercise for osteoarthritis of the hip
Comparison: 1 Immediate post treatment
Outcome: 2 Physical function
Study or subgroup Exercise Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 End of treatment scores
Foley 2003 6 27 (7.4) 12 30.7 (10.4) 5.1 % -0.37 [ -1.36, 0.62 ]
Tak 2005 23 22.5 (5) 25 25.5 (6.2) 11.3 % -0.52 [ -1.10, 0.06 ]
Fransen 2007 15 20 (9.82) 5 30.8 (11.03) 4.5 % -1.02 [ -2.10, 0.05 ]
Fernandes 2010 55 17.9 (14.3) 54 22.5 (17) 17.5 % -0.29 [ -0.67, 0.09 ]
Juhakoski 2011 60 25.3 (21.1) 58 27 (19.7) 18.1 % -0.08 [ -0.44, 0.28 ]
French 2013 45 28.08 (15.48) 43 36.09 (16.41) 15.8 % -0.50 [ -0.92, -0.07 ]
Subtotal (95% CI) 204 197 72.2 % -0.33 [ -0.53, -0.13 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 4.48, df = 5 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 3.23 (P = 0.0012)
2 Change scores
van Baar 1998 35 0.61 (4.12) 33 -0.81 (3.8) 14.0 % 0.35 [ -0.13, 0.83 ]
Hopman-Rock 2000 10 0 (3.8) 12 1 (4.1) 6.6 % -0.24 [ -1.09, 0.60 ]
Carlson 2011 20 -10 (9.9) 10 -1.2 (9.6) 7.2 % -0.87 [ -1.67, -0.08 ]
Subtotal (95% CI) 65 55 27.8 % -0.20 [ -0.96, 0.55 ]
Heterogeneity: Tau2 = 0.32; Chi2 = 7.02, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.52 (P = 0.60)
Total (95% CI) 269 252 100.0 % -0.30 [ -0.54, -0.05 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 13.53, df = 8 (P = 0.09); I2 =41%
Test for overall effect: Z = 2.37 (P = 0.018)
Test for subgroup differences: Chi2 = 0.10, df = 1 (P = 0.75), I2 =0.0%
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Analysis 1.3. Comparison 1 Immediate post treatment, Outcome 3 Quality of life.
Review: Exercise for osteoarthritis of the hip
Comparison: 1 Immediate post treatment
Outcome: 3 Quality of life
Study or subgroup Exercise Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 End of treatment scores
Tak 2005 36 5.9 (2) 39 5.5 (2.3) 42.0 % 0.18 [ -0.27, 0.64 ]
Fransen 2007 15 49.34 (5.43) 5 51.32 (7.98) 8.4 % -0.31 [ -1.33, 0.71 ]
French 2013 45 48.92 (12.5) 43 48.52 (13.75) 49.6 % 0.03 [ -0.39, 0.45 ]
Subtotal (95% CI) 96 87 100.0 % 0.07 [ -0.23, 0.36 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.81, df = 2 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 0.44 (P = 0.66)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Immediate post treatment, Outcome 4 Study withdrawals.
Review: Exercise for osteoarthritis of the hip
Comparison: 1 Immediate post treatment
Outcome: 4 Study withdrawals
Study or subgroup Exercise Control
Risk
Difference Weight
Risk
Difference
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
van Baar 1998 6/99 4/102 15.7 % 0.02 [ -0.04, 0.08 ]
Foley 2003 3/35 3/35 4.1 % 0.0 [ -0.13, 0.13 ]
Tak 2005 10/55 5/54 4.3 % 0.09 [ -0.04, 0.22 ]
Fransen 2007 1/15 0/5 1.1 % 0.07 [ -0.20, 0.33 ]
Fernandes 2010 0/55 0/54 31.5 % 0.0 [ -0.04, 0.04 ]
Juhakoski 2011 0/60 0/58 34.1 % 0.0 [ -0.03, 0.03 ]
French 2013 3/45 0/43 9.3 % 0.07 [ -0.02, 0.15 ]
Total (95% CI) 364 351 100.0 % 0.01 [ -0.01, 0.04 ]
Total events: 23 (Exercise), 12 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 7.79, df = 6 (P = 0.25); I2 =23%
Test for overall effect: Z = 1.01 (P = 0.31)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Sustainability (three to six months), Outcome 1 Pain.
Review: Exercise for osteoarthritis of the hip
Comparison: 2 Sustainability (three to six months)
Outcome: 1 Pain
Study or subgroup Exercise Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 End of treatment
Tak 2005 35 3.5 (2.1) 39 5.1 (2.3) 18.1 % -0.72 [ -1.19, -0.25 ]
Fernandes 2010 47 16.8 (17) 42 23.4 (19.6) 22.9 % -0.36 [ -0.78, 0.06 ]
Juhakoski 2011 60 23.4 (20.9) 58 28.9 (21.3) 30.6 % -0.26 [ -0.62, 0.10 ]
Abbott 2013 22 11.45 (12.97) 23 15.26 (13) 11.7 % -0.29 [ -0.88, 0.30 ]
Subtotal (95% CI) 164 162 83.3 % -0.39 [ -0.61, -0.17 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.49, df = 3 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 3.48 (P = 0.00051)
2 Change scores
van Baar 1998 34 -11.68 (44) 31 1.26 (30.1) 16.7 % -0.34 [ -0.83, 0.15 ]
Subtotal (95% CI) 34 31 16.7 % -0.34 [ -0.83, 0.15 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.34 (P = 0.18)
Total (95% CI) 198 193 100.0 % -0.38 [ -0.58, -0.18 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.53, df = 4 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 3.72 (P = 0.00020)
Test for subgroup differences: Chi2 = 0.04, df = 1 (P = 0.84), I2 =0.0%
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Analysis 2.2. Comparison 2 Sustainability (three to six months), Outcome 2 Physical function.
Review: Exercise for osteoarthritis of the hip
Comparison: 2 Sustainability (three to six months)
Outcome: 2 Physical function
Study or subgroup Exercise Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 End of treatment
Tak 2005 23 23.7 (5.4) 25 26.3 (6.3) 13.1 % -0.43 [ -1.01, 0.14 ]
Fernandes 2010 47 15.8 (15.9) 42 24.2 (18.4) 24.1 % -0.49 [ -0.91, -0.06 ]
Juhakoski 2011 60 22.6 (17.8) 58 30.1 (19) 32.3 % -0.40 [ -0.77, -0.04 ]
Abbott 2013 22 41.05 (43.75) 23 58.78 (46.64) 12.3 % -0.38 [ -0.98, 0.21 ]
Subtotal (95% CI) 152 148 81.9 % -0.43 [ -0.66, -0.20 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.11, df = 3 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 3.68 (P = 0.00023)
2 Change scores
van Baar 1998 34 -0.54 (4.36) 31 -0.21 (4.83) 18.1 % -0.07 [ -0.56, 0.42 ]
Subtotal (95% CI) 34 31 18.1 % -0.07 [ -0.56, 0.42 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.29 (P = 0.77)
Total (95% CI) 186 179 100.0 % -0.37 [ -0.57, -0.16 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.82, df = 4 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 3.45 (P = 0.00056)
Test for subgroup differences: Chi2 = 1.71, df = 1 (P = 0.19), I2 =42%
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Analysis 3.1. Comparison 3 Hip osteoarthritis (OA) versus hip/knee OA studies, Outcome 1 Pain post
treatment.
Review: Exercise for osteoarthritis of the hip
Comparison: 3 Hip osteoarthritis (OA) versus hip/knee OA studies
Outcome: 1 Pain post treatment
Study or subgroup Exercise Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Hip OA only
Tak 2005 35 3.6 (2.5) 39 4.1 (2.1) 14.0 % -0.22 [ -0.67, 0.24 ]
Fernandes 2010 55 20.6 (17.21) 54 25.3 (18.5) 20.6 % -0.26 [ -0.64, 0.12 ]
Carlson 2011 20 -9.3 (15) 10 -4.2 (11) 5.0 % -0.36 [ -1.12, 0.41 ]
Juhakoski 2011 60 24.1 (21.7) 58 27.8 (19.8) 22.4 % -0.18 [ -0.54, 0.18 ]
French 2013 45 4.02 (2.88) 43 5.62 (2.84) 16.1 % -0.55 [ -0.98, -0.13 ]
Subtotal (95% CI) 215 204 78.0 % -0.30 [ -0.49, -0.10 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.01, df = 4 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 2.99 (P = 0.0028)
2 Hip/knee OA
van Baar 1998 35 26 (25.85) 33 43.42 (21.61) 12.1 % -0.72 [ -1.21, -0.23 ]
Hopman-Rock 2000 11 37 (26) 13 47.2 (20.5) 4.4 % -0.43 [ -1.24, 0.39 ]
Foley 2003 6 9 (3.58) 12 10.58 (4.12) 3.0 % -0.38 [ -1.37, 0.61 ]
Fransen 2007 15 5.57 (3.18) 5 9.2 (3.35) 2.5 % -1.08 [ -2.16, 0.00 ]
Subtotal (95% CI) 67 63 22.0 % -0.66 [ -1.02, -0.29 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.27, df = 3 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 3.53 (P = 0.00042)
Total (95% CI) 282 267 100.0 % -0.38 [ -0.55, -0.20 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 6.21, df = 8 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 4.30 (P = 0.000017)
Test for subgroup differences: Chi2 = 2.93, df = 1 (P = 0.09), I2 =66%
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Analysis 3.2. Comparison 3 Hip osteoarthritis (OA) versus hip/knee OA studies, Outcome 2 Physical
function post treatment.
Review: Exercise for osteoarthritis of the hip
Comparison: 3 Hip osteoarthritis (OA) versus hip/knee OA studies
Outcome: 2 Physical function post treatment
Study or subgroup Exercise Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Hip OA only
Tak 2005 23 22.5 (5) 25 25.5 (6.2) 11.3 % -0.52 [ -1.10, 0.06 ]
Fernandes 2010 55 17.9 (14.3) 54 22.5 (17) 17.5 % -0.29 [ -0.67, 0.09 ]
Carlson 2011 20 -10 (9.9) 10 -1.2 (9.6) 7.2 % -0.87 [ -1.67, -0.08 ]
Juhakoski 2011 60 25.3 (21.1) 58 27 (19.7) 18.1 % -0.08 [ -0.44, 0.28 ]
French 2013 45 28.08 (15.48) 43 36.09 (16.41) 15.8 % -0.50 [ -0.92, -0.07 ]
Subtotal (95% CI) 203 190 69.8 % -0.35 [ -0.57, -0.13 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 4.66, df = 4 (P = 0.32); I2 =14%
Test for overall effect: Z = 3.11 (P = 0.0019)
2 Hip/knee OA
van Baar 1998 35 0.61 (4.12) 33 -0.81 (3.8) 14.0 % 0.35 [ -0.13, 0.83 ]
Hopman-Rock 2000 10 0 (3.8) 12 1 (4.1) 6.6 % -0.24 [ -1.09, 0.60 ]
Foley 2003 6 27 (7.4) 12 30.7 (10.4) 5.1 % -0.37 [ -1.36, 0.62 ]
Fransen 2007 15 20 (9.82) 5 30.8 (11.03) 4.5 % -1.02 [ -2.10, 0.05 ]
Subtotal (95% CI) 66 62 30.2 % -0.20 [ -0.79, 0.40 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 6.44, df = 3 (P = 0.09); I2 =53%
Test for overall effect: Z = 0.65 (P = 0.52)
Total (95% CI) 269 252 100.0 % -0.30 [ -0.54, -0.05 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 13.53, df = 8 (P = 0.09); I2 =41%
Test for overall effect: Z = 2.37 (P = 0.018)
Test for subgroup differences: Chi2 = 0.22, df = 1 (P = 0.64), I2 =0.0%
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. exp osteoarthritis/
2. osteoarthr$.tw.
3. (degenerative adj2 arthritis).tw.
4. arthrosis.tw.
5. or/1-4
6. Hip/
7. exp Hip Joint/
8. hip$.tw.
9. or/6-8
10. exp EXERCISE/
11. exp exertion/
12. exp Physical Fitness/
13. exp Exercise Test/
14. exp Exercise Tolerance/
15. exp Sports/
16. exp PLIABILITY/
17. exp Physical Endurance/
18. exertion$.tw.
19. exercis$.tw.
20. sport$.tw.
21. ((physical or motion) adj5 (fitness or therap$)).tw.
22. (physical$ adj2 endur$).tw.
23. ((strength$ or isometric$ or isotonic$ or isokinetic$ or aerobic$ or endurance or weight$) adj5 (exercis$ or train$)).tw.
24. exp physical therapy modalities/
25. physiotherap$.tw.
26. manipulat$.tw.
27. kinesiotherap$.tw.
28. exp Rehabilitation/
29. rehab$.tw.
30. (skate$ or skating).tw.
31. run$.tw.
32. jog$.tw.
33. treadmill$.tw.
34. swim$.tw.
35. bicycl$.tw.
36. (cycle$ or cycling).tw.
37. walk$.tw.
38. (row or rows or rowing).tw.
39. muscle strength$.tw.
40. or/10-39
41. randomized controlled trial.pt.
42. controlled clinical trial.pt.
43. randomized.ab.
44. placebo.ab.
45. drug therapy.fs.
46. randomly.ab.
47. trial.ab.
48. groups.ab.
49. 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48
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50. humans.sh.
51. 49 and 50
52. and/5,9,40,51
Appendix 2. EMBASE search strategy
1. exp osteoarthritis/
2. osteoarthr$.tw.
3. (degenerative adj2 arthritis).tw.
4. arthrosis.tw.
5. or/1-4
6. Hip/
7. hip$.tw.
8. 6 or 7
9. exp EXERCISE/
10. fitness/
11. exercise test/
12. exercise tolerance/
13. exp Sport/
14. pliability/
15. exp “physical activity, capacity and performance”/
16. exertion$.tw.
17. exercis$.tw.
18. sport$.tw.
19. ((physical or motion) adj5 (fitness or therap$)).tw.
20. (physical$ adj2 endur$).tw.
21. ((strength$ or isometric$ or isotonic$ or isokinetic$ or aerobic$ or endurance or weight$) adj5 (exercis$ or train$)).tw.
22. exp physiotherapy/
23. physiotherap$.tw.
24. manipulat$.tw.
25. kinesiotherap$.tw.
26. exp REHABILITATION/
27. rehab$.tw.
28. (skate$ or skating).tw.
29. run$.tw.
30. jog$.tw.
31. treadmill$.tw.
32. swim$.tw.
33. bicycl$.tw.
34. (cycle$ or cycling).tw.
35. walk$.tw.
36. (row or rows or rowing).tw.
37. muscle strength$.tw.
38. or/9-37
39. and/5,8,38
40. random$.ti,ab.
41. factorial$.ti,ab.
42. (crossover$ or cross over$ or cross-over$).ti,ab.
43. placebo$.ti,ab.
44. (doubl$ adj blind$).ti,ab.
45. (singl$ adj blind$).ti,ab.
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46. assign$.ti,ab.
47. allocat$.ti,ab.
48. volunteer$.ti,ab.
49. crossover procedure.sh.
50. double blind procedure.sh.
51. randomized controlled trial.sh.
52. single blind procedure.sh.
53. or/40-52
54. exp animal/ or nonhuman/ or exp animal experiment/
55. exp human/
56. 54 and 55
57. 54 not 56
58. 53 not 57
59. 39 and 58
Appendix 3. PEDRO search strategy
Advanced search
Therapy: Fitness training OR Strength training
Body Part: Thigh or hip
Appendix 4. CINAHL search strategy
S56 S55 and S42
S55 S54 or S53 or S52 or S51 or S50 or S49 or S48 or S47 or S46 or S45 or S44 or S43 S54 TI Allocat* random* or AB Allocat*
random*
S53 (MH “Quantitative Studies”)
S52 (MH “Placebos”)
S51 TI Placebo* or AB Placebo*
S50 TI Random* allocat* or AB Random* allocat*
S49 (MH “Random Assignment”)
S48 TI Randomi?ed control* trial* or AB Randomi?ed control* trial*
S47 TI singl* mask* or TI doubl* mask* or TI treb* mask* or TI tripl* mask* or AB singl* mask* or AB doubl* mask* or AB treb*
mask* or AB tripl* mask*
S46 TI singl* blind* or TI doubl* blind* or TI treb* blind* or TI tripl* blind* or AB singl* blind* or AB doubl* blind* or AB treb*
blind* or AB tripl* blind*
S45 TI “clinic* trial*” or AB “clinic* trial*”
S44 PT Clinical Trial
S43 (MH “Clinical Trials+”)
S42 S41 and S40 and S5
S41 S39 or S38 or S37 or S36 or S35 or S34 or S33 or S32 or S31 or S30 or S29 or S28 or S27 or S26 or S25 or S24 or S23 or S22
or S21 or S20 or S19 or S18 or S17 or S16 or S15 or S14 or S13 or S12 or S11 or S10 or S9 or S8 or S7 or S6
S40 S8 or S7 or S6
S39 (ti “muscle strength*”) or (ab “muscle strength*”)
S38 (ti row or rows or rowing) or (ab row or rows or rowing)
S37 (ti walk*) or (ab walk*)
S36 (ti cycle* or cycling) or (ab cycle* or cycling)
S35 (ti bicycl*) or (ab bicycl*)
S34 (ti swim*) or (ab swim*)
S33 (ti swim*) or (ab swim*)
S32 (ti treadmill*) or (ab treadmill*)
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S31 (ti jog*) or (ab jog*)
S30 (ti run*) or (ab run*)
S29 (ti skate* or skating) or (ab skate* or skating)
S28 (ti rehab*) or (ab rehab*)
S27 (MH “Rehabilitation+”)
S26 (ti kinesiotherap*) or (ab kinesiotherap*)
S25 (ti manipulat*) or (ab manipulat*)
S24 (ti physiotherap*) or (ab physiotherap*)
S23 (MH “Physical Therapy+”)
S22 TI ( strength* or isometric* or isotonic* or isokinetic*or aerobic* or endurance or weight* ) or AB ( strength* or isometric* or
isotonic* or isokinetic*or aerobic* or endurance or weight* )
S21 TI physical* n2 endur* or AB physical* n2 endur*
S20 TI physical N5 fitness or TI physical N5 therap* or AB physical N5 fitness or AB physical N5 therap* or TI motion n5 therap*
or AB motion n5 therap*
S19 (ti sport*) or (ab sport*)
S18 (ti exercis*) or (ab exercis*)
S17 (ti exertion*) or (ab exertion*)
S16 (MH “Physical Endurance+”)
S15 (MH “Pliability
S14 (MH ”Sports+“)
S13 (MH ”Exercise Tolerance+“)
S12 (MH ”Exercise Test+“)
S11 (MH ”Physical Fitness“)
S10 (MH ”Exertion+“)
S9 (MH ”Exercise+“)
S8 (ti hip*) or (ab hip*)
S7 (MH ”Hip Joint
S6 (MH “Hip”)
S5 S4 or S3 or S2 or S1
S4 (ti arthrosis) or (ab arthrosis)
S3 (ti degenerative N2 arthritis) or (ab degenerative N2 arthritis)
S2 (ti osteoarthr*) or (ab osteoarthr*)
S1 (MH “Osteoarthritis+”)
Appendix 5. The Cochrane Library search strategy
MeSH descriptor Osteoarthritis explode all treesosteoarthr*:ti,ab(degenerative next arthritis):ti,abarthrosis:ti,ab(#1 OR #2 OR #3 OR
#4)MeSH descriptor Knee explode all treesMeSH descriptor Knee Joint explode all treesknee*:ti,ab(#6 OR #7 OR #8)MeSH de-
scriptor Exercise explode all treesMeSH descriptor Exertion explode all treesMeSH descriptor Physical Fitness explode all treesMeSH
descriptor Exercise Test explode all treesMeSH descriptor Exercise Tolerance explode all treesMeSH descriptor Sports explode
all treesMeSH descriptor Pliability explode all treesMeSH descriptor Physical Endurance explode all treesexertion*:ti,abexercis*:
ti,absport*:ti,ab((physical or motion) near/5 (fitness or therap*)):ti,ab(physical* near/2 endur*):ti,ab((strength* or isometric* or iso-
tonic* or isokinetic* or aerobic* or endurance or weight*) near/5 (exercis* or train*)):ti,abMeSH descriptor Physical Therapy Modal-
ities explode all trees(physical next therap*):ti,abphysiotherap*:ti,abmanipulat*:ti,abkinesiotherap*:ti,abMeSH descriptor Rehabilita-
tion explode all treesrehab*:ti,ab(skate* or skating):ti,abrun*:ti,abjog*:ti,abtreadmill*:ti,abswim*:ti,abbicycl*:ti,ab(cycle* or cycling):
ti,abwalk*:ti,ab(row or rows or rowing):ti,abmuscle next strength:ti,ab(#10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR
#17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR
#32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40)(#5 AND #9 AND #41)
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WH A T ’ S N E W
Last assessed as up-to-date: 9 May 2013.
Date Event Description
24 March 2014 New citation required and conclusions have changed Change in conclusions on update: significant benefit in
terms of physical function now demonstrated
Methods were updated in accordance with current
Cochrane Collaboration recommendations: risk of bias as-
sessment and Summary of Findings Tables added
Quality of life assessment and study withdrawal rates were
added in the update
Pain and physical function outcomes were further disag-
gregated into immediate post treatment effects and sus-
tainability (3-6 months post treatment)
9 May 2013 New search has been performed Five new studies added to this update: Fernandes 2010;
Juhakoski 2011; Carlson 2011; French 2013; Abbott 2013
H I S T O R Y
Review first published: Issue 3, 2009
Date Event Description
19 April 2009 New citation required but conclusions have not changed Substantive amendment
14 January 2009 New search has been performed This updated review is one of two Cochrane reviews
replacing an earlier review, ’Exercise for osteoarthritis of
the hip or knee’. Since the original review, the editors
decided to subdivide the review into separate conditions.
The Background section has been revised to provide in-
formation on the specific disorder only, and the search
strategy has been revised accordingly. TheMethods sec-
tion has been updated to reflect current Cochrane Mus-
culoskeletal Group methods.
3 new studies were added in this updated review: Foley
2003; Fransen 2007; Tak 2005
14 January 2009 Amended Converted to new review format. CMSG ID added
A040-R
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C O N T R I B U T I O N S O F A U T H O R S
Three review authors (SM, MF, GH) independently screened retrieved clinical studies for inclusion, extracted data from all included
studies and conducted the methodological quality assessment. If we did not reach an agreement at any stage, a fourth review author
(SR) adjudicated. All four review authors reviewed the final manuscript prior to submission.
D E C L A R A T I O N S O F I N T E R E S T
None.
S O U R C E S O F S U P P O R T
Internal sources
• S Reichenbach is funded by the Swiss National Science Foundation’s National Research Program 53 on musculoskeletal health
(grant no. 4053-40-104762), and the Mäxi Foundation, Switzerland.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We have updated the methods in the review since the original protocol, in accordance with the current recommended methods of
the Cochrane Musculoskeletal Group, and The Cochrane Collaboration. The original protocol was for a review entitled “Exercise for
osteoarthritis of the hip or knee”. Since the original review, the editors decided to subdivide the review into two reviews of separate
conditions. For this update of the specific review for hip OA, we have added two more outcomes: quality of life and study withdrawal
rates. We have also now conducted a sensitivity analysis according to recruitment criteria, comparing studies recruiting only participants
with hip OA with those recruiting participants with hip or knee OA.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Exercise Therapy; ∗Hip Joint; Arthralgia [∗therapy]; Osteoarthritis, Hip [∗therapy]; Randomized Controlled Trials as Topic
MeSH check words
Humans
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